Harry Shufflebarger
Orthopaedic Surgery of the Spine Miami, FL Medical Doctor
NPI 1053369918 CMS profile 2632
3100 Sw 62Nd Ave, Orthopaedic Dept, Miami, FL 33155
General payments
$3,488,056
Research payments
$0
Ownership & investment interest
$600,000
Through program year 2025, Harry Shufflebarger of Miami, FL is reported in the CMS Open Payments database as having received $3,488,056 across 189 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $600,000 across 3 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $467,662 | 4 | |
| 2024 | General | $484,670 | 6 | |
| 2023 | General | $499,514 | 20 | |
| 2022 | General | $965,336 | 24 | |
| 2021 | General | $476,379 | 48 | |
| 2020 | General | $330,116 | 28 | |
| 2019 | General | $264,380 | 59 | |
| 2021 | Ownership | $200,000 | 1 | |
| 2020 | Ownership | $200,000 | 1 | |
| 2019 | Ownership | $200,000 | 1 |
Beside peers
- Harry Shufflebarger
- Orthopaedic Surgery of the Spine median
- Middle half of Orthopaedic Surgery of the Spine
- National median
In program year 2025, general payments to Harry Shufflebarger were reported at $467,662. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.
Show as a table
| Year | Harry Shufflebarger | Orthopaedic Surgery of the Spine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $264,380 | $2,106 | $337–$18,608 | $163 |
| 2020 | $330,116 | $1,213 | $156–$15,082 | $114 |
| 2021 | $476,379 | $1,834 | $271–$15,617 | $132 |
| 2022 | $965,336 | $2,015 | $320–$17,036 | $149 |
| 2023 | $499,514 | $1,925 | $336–$14,599 | $160 |
| 2024 | $484,670 | $2,110 | $341–$12,483 | $164 |
| 2025 | $467,662 | $2,061 | $347–$14,651 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
189 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Orthopaedic Surgery of the Spine in Florida
Paul Keller
Orthopaedic Surgery of the Spine · Melbourne, FL
Thomas Sweeney
Orthopaedic Surgery of the Spine · Sarasota, FL
Geoffrey Cronen
Orthopaedic Surgery of the Spine · Tampa, FL
James Billys
Orthopaedic Surgery of the Spine · Odessa, FL
Mark Dekutoski
Orthopaedic Surgery of the Spine · Destin, FL
Farhan Siddiqi
Orthopaedic Surgery of the Spine · Odessa, FL
Related records
Orthopaedic Surgery of the Spine in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Orthopaedic Surgery of the Spine
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.